Finally, see a more complete picture of your diabetes therapy - in real- time!*
For the first time, you can use an insulin pen without sacrificing data and decision support. The InPen™ + Guardian™ Connect system enhances how you manage MDI because it tracks your data in real- time and gives you personalized recommendations.
See your current CGM reading, updated every 5 minutes. Arrows indicate which direction your sensor glucose (SG) is rising or falling.
At any time, you can check the app and see how much insulin is still active in your body from previous doses.
Can't remember your last dose? All InPen™ delivered doses are automatically logged in the app, giving you full visibility of prior doses.
See how your glucose levels fluctuate over time, alongside your carb intake and dose history.
See how your meals and carb intake impact your glucose levels.
InPen™ reports help you visualize how insulin and meals affect glucose so that you can make informed adjustments. It's easy to share reports with your healthcare provider or family members.
The Guardian™ Connect system provides real-time readings with sensor glucose data sent to your compatible smartphone every five minutes. At your fingertips you’ll see your current sensor glucose and trend direction including predictive and threshold alerts. The Guardian™ Connect system detects up to 90.5% of lows without predictive alerts turned on and 98.5% of lows with the help of predictive alerts.1,2
Already have a Guardian™ Connect and interested in learning more about InPen™?
Interested in learning more about the InPen™ + Guardian™ Connect system? Please complete the form below or call 888-882-8602 and one of our Diabetes Therapy consultants will be happy to assist you.
The InPen™ is the only FDA-cleared smart3 insulin pen that combines the freedom of Bluetooth® technology and intelligence through an easy to use smartphone app, helping people administer correction and meal-time insulin doses.
Yes, the i-Port Advance™ injection port is compatible with the InPen™. Needles used with the i-Port Advance™ injection port need to be 5-8mm (3/16-5/16”) in length and 32-28 gauge.
* Data may not appear or be delayed in certain instances, including when there is no internet connection.
1. Guardian™ Connect system SSED, page 19, Table 5. 90.5% Glucose Correct Detection Rate without Predictive Alerts at both 15 and 30 minutes when worn on the abdomen.
2. Guardian™ Connect system SSED, page 19, Table 5. 98.5% Glucose Correct Detection Rate based on Predictive Alerts at 30 minutes when worn on the abdomen.
3. Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.
Each InPen™ is reusable for one year. Offer available to eligible patients with commercial insurance. Terms and conditions apply. Learn more.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
Important Safety Information: InPen™
The InPen™ is a home- use reusable pen injector for single- patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self- injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient- specific criteria and targets. The InPen™ requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenRisks.com.
Rx only. Under age 7 requires supervision of an adult caregiver. User interaction, compatible device, proper pairing and settings required. See http://bit.ly/InPenSafety